These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20740332)

  • 21. Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.
    Vranić E; Uzunović A
    Bosn J Basic Med Sci; 2007 Nov; 7(4):328-34. PubMed ID: 18039191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.
    Collier JW; Shah RB; Gupta A; Sayeed V; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Jun; 11(2):818-25. PubMed ID: 20454876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
    Hancock BC; Garcia-Munoz S
    J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight uniformity of split tablets required by a Veterans Affairs policy.
    Polli JE; Kim S; Martin BR
    J Manag Care Pharm; 2003; 9(5):401-7. PubMed ID: 14613437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tablet splitting].
    Quinzler R; Haefeli WE
    Ther Umsch; 2006 Jun; 63(6):441-7. PubMed ID: 16841582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
    Richheimer SL; Amer TM
    J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
    Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
    J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of hydration state and molecular oxygen on the chemical stability of levothyroxine sodium.
    Hamad ML; Engen W; Morris KR
    Pharm Dev Technol; 2015 May; 20(3):314-9. PubMed ID: 24295156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial Dehydration of Levothyroxine Sodium Pentahydrate in a Drug Product Environment: Structural Insights into Stability.
    Kaur N; Young VG; Su Y; Suryanarayanan R
    Mol Pharm; 2020 Oct; 17(10):3915-3929. PubMed ID: 32960611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tablet splitting: a review of weight and content uniformity.
    Freeman MK; White W; Iranikhah M
    Consult Pharm; 2012 May; 27(5):341-52. PubMed ID: 22591978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical counselling about different types of tablet-splitting methods based on the results of weighing tests and mechanical development of splitting devices.
    Somogyi O; Meskó A; Csorba L; Szabó P; Zelkó R
    Eur J Pharm Sci; 2017 Aug; 106():262-273. PubMed ID: 28606803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
    Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
    J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tablet Compression Force as a Process Analytical Technology (PAT): 100% Inspection and Control of Tablet Weight Uniformity.
    Manley L; Hilden J; Valero P; Kramer T
    J Pharm Sci; 2019 Jan; 108(1):485-493. PubMed ID: 30009799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations.
    Nidanapu RP; Rajan S; Mahadevan S; Gitanjali B
    Paediatr Drugs; 2016 Dec; 18(6):451-463. PubMed ID: 27704404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of formulation variables on weight uniformity of scored tablets using factorial design.
    Zaid AN; Hawari R; Malkieh N; Natshih Y; Yousef A; Jaradat N; Hammad A; Basharat R
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2501-2507. PubMed ID: 31894042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of excipients on the stability of levothyroxine sodium tablets.
    Das Gupta V; Odom C; Bethea C; Plattenburg J
    J Clin Pharm Ther; 1990 Oct; 15(5):331-6. PubMed ID: 2289935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer.
    Ashrafpour R; Ayati N; Sadeghi R; Zare Namdar S; Ayati N; Ghahremani S; Zakavi SR
    Asia Ocean J Nucl Med Biol; 2018; 6(2):108-112. PubMed ID: 29998143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real time release testing of tablet content and content uniformity.
    Goodwin DJ; van den Ban S; Denham M; Barylski I
    Int J Pharm; 2018 Feb; 537(1-2):183-192. PubMed ID: 29229511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.